144 related articles for article (PubMed ID: 33531872)
1. P21 is not a prognostic marker for rectal cancer - five-year follow up study of rectal cancer in stages I-IV.
Kozłowska-Geller MA; Głuszek SZ; Lewitowicz P
Contemp Oncol (Pozn); 2020; 24(4):247-251. PubMed ID: 33531872
[TBL] [Abstract][Full Text] [Related]
2. Five-year follow-up study of stage I-IV rectal cancer including EGFR immunoexpression and p21 immunoactivity.
Kozłowska-Geller M; Głuszek S; Lewitowicz P
Prz Gastroenterol; 2021; 16(4):330-338. PubMed ID: 34976241
[TBL] [Abstract][Full Text] [Related]
3. Value of expression of p21WAF1/CIP1 as a prognostic factor in advanced middle and lower rectal cancer patients treated with preoperative radio-chemotherapy.
Sogawa N; Takiguchi N; Koda K; Oda K; Satomi D; Kato K; Ishikura H; Miyazaki M
Int J Oncol; 2002 Oct; 21(4):787-93. PubMed ID: 12239617
[TBL] [Abstract][Full Text] [Related]
4. p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance?
Schwandner O; Bruch HP; Broll R
Int J Colorectal Dis; 2002 Jan; 17(1):11-9. PubMed ID: 12018448
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p21 and p27 protein, apoptosis, clinical and histologic factors in rectal cancer without lymph node metastases.
Schwandner O; Bruch HP; Broll R
Eur Surg Res; 2002; 34(6):389-96. PubMed ID: 12403937
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of p53, p21, and p27 expressions in rectal carcinoma.
Lebe B; Sarioğlu S; Sökmen S; Ellidokuz H; Füzün M; Küpelioğlu A
Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):38-44. PubMed ID: 15722792
[TBL] [Abstract][Full Text] [Related]
7. Dynamic expression profile of p21WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy.
Rau B; Sturm I; Lage H; Berger S; Schneider U; Hauptmann S; Wust P; Riess H; Schlag PM; Dörken B; Daniel PT
J Clin Oncol; 2003 Sep; 21(18):3391-401. PubMed ID: 12885834
[TBL] [Abstract][Full Text] [Related]
8. A five-year follow up study of stage I-IV of rectal cancer with an emphasis on epidermal growth factor over-expression.
Kozłowska-Geller MA; Lewitowicz P; Głuszek SZ
Pol J Pathol; 2021; 72(2):124-129. PubMed ID: 34706519
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of apoptosis mediators in rectal adenocarcinoma.
Seicean R; Crisan D; Boers JE; Mocan T; Seicean A; Funariu G; Ciuce C
Hepatogastroenterology; 2011; 58(110-111):1490-4. PubMed ID: 21940317
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival.
Elkablawy MA; Maxwell P; Williamson K; Anderson N; Hamilton PW
J Pathol; 2001 Aug; 194(4):436-43. PubMed ID: 11523051
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP
Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812
[TBL] [Abstract][Full Text] [Related]
12. The early response of p53-dependent proteins during radiotherapy in human rectal carcinoma and in adjacent normal tissue.
Stift A; Prager G; Selzer E; Widder J; Kandioler D; Friedl J; Teleky B; Herbst F; Wrba F; Bergmann M
Int J Oncol; 2003 Nov; 23(5):1269-75. PubMed ID: 14532965
[TBL] [Abstract][Full Text] [Related]
13. Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer.
Stein JP; Ginsberg DA; Grossfeld GD; Chatterjee SJ; Esrig D; Dickinson MG; Groshen S; Taylor CR; Jones PA; Skinner DG; Cote RJ
J Natl Cancer Inst; 1998 Jul; 90(14):1072-9. PubMed ID: 9672255
[TBL] [Abstract][Full Text] [Related]
14. p21 and p53 Immunostaining and survival following systemic chemotherapy for urothelial cancer.
Jankevicius F; Goebell P; Kushima M; Schulz WA; Ackermann R; Schmitz-Dräger BJ
Urol Int; 2002; 69(3):174-80. PubMed ID: 12372883
[TBL] [Abstract][Full Text] [Related]
15. Prognostic values of radiation-induced p53 in adjacent normal mucosa and p21WAF1/CIP1 expression in rectal cancer patients.
Yoshikawa R; Yanagi H; Kusunoki M; Fujiwara Y; Noda M; Hashimoto-Tamaoki T; Yamamura T
Int J Oncol; 2002 Dec; 21(6):1223-8. PubMed ID: 12429971
[TBL] [Abstract][Full Text] [Related]
16. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC
J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.
Pietras RJ; Poen JC; Gallardo D; Wongvipat PN; Lee HJ; Slamon DJ
Cancer Res; 1999 Mar; 59(6):1347-55. PubMed ID: 10096569
[TBL] [Abstract][Full Text] [Related]
18. p53 expression in human rectal tissue after radiotherapy: upregulation in normal mucosa versus functional loss in rectal carcinomas.
Marijnen CA; Kapiteijn E; Nagtegaal ID; Mulder-Stapel AA; van de Velde CJ; Schrier PI; Peltenburg LT; van Krieken JH
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):720-8. PubMed ID: 11849795
[TBL] [Abstract][Full Text] [Related]
19. Relationship of p21(WAF-I) protein expression with prognosis in advanced prostate cancer treated by androgen ablation.
Omar EA; Behlouli H; Chevalier S; Aprikian AG
Prostate; 2001 Nov; 49(3):191-9. PubMed ID: 11746264
[TBL] [Abstract][Full Text] [Related]
20. Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression.
Baretton GB; Klenk U; Diebold J; Schmeller N; Löhrs U
Br J Cancer; 1999 May; 80(3-4):546-55. PubMed ID: 10408865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
